Editor’s Note: This interview was conducted at #Bio2018. Please pardon the background noise.
Dr. Joe Trebley, Co-founder and CEO of Scioto Biosciences, discusses his company’s focus on developing a novel probiotic delivery platform that provides enhanced function and persistent probiotic benefits to patients. The microbiome market is a fairly new field of research. Although there are several products sold over the counter that currently claim to prevent various human diseases, few have significant impact or improvement in the outcome for patients.